Hikma Pharmaceuticals PLC announced the following changes to its board of directors and their responsibilities: Dr. Pamela Kirby has decided not to stand for re-election at the next annual general meeting of the Company that is scheduled to take place on 25 April 2022; and Nina Henderson will take over as chair of the Remuneration Committee with effect from the end of the annual general meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,930 GBX | +0.89% | -1.43% | +7.88% |
05-28 | Egypt, UAE talks continuing over Ras El Hekma land deal | RE |
05-17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.88% | 5.45B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Hikma Pharmaceuticals Announces Directorate Change